BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25684943)

  • 1. In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM.
    Takino J; Nagamine K; Takeuchi M; Hori T
    World J Gastroenterol; 2015 Feb; 21(6):1784-93. PubMed ID: 25684943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
    Takino J; Kobayashi Y; Takeuchi M
    J Gastroenterol; 2010 Jun; 45(6):646-55. PubMed ID: 20084527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of glyceraldehyde-derived advanced glycation end-products in the liver of insulin-resistant mice.
    Ebata Y; Takino J; Tsuchiya H; Sakabe T; Ikeda Y; Hama S; Kogure K; Takeuchi M; Shiota G
    Int J Vitam Nutr Res; 2013; 83(2):137-41. PubMed ID: 24491887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.
    Takino J; Yamagishi S; Takeuchi M
    World J Gastroenterol; 2012 Apr; 18(15):1781-8. PubMed ID: 22553402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products.
    Matsui T; Joo HD; Lee JM; Ju SM; Tao WH; Higashimoto Y; Fukami K; Yamagishi S
    Immunol Lett; 2015 Oct; 167(2):141-6. PubMed ID: 26304702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death.
    Sakasai-Sakai A; Takata T; Takino JI; Takeuchi M
    Sci Rep; 2017 Oct; 7(1):14282. PubMed ID: 29079763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia.
    Takeda M; Ohnuma T; Takeuchi M; Katsuta N; Maeshima H; Takebayashi Y; Higa M; Nakamura T; Nishimon S; Sannohe T; Hotta Y; Hanzawa R; Higashiyama R; Shibata N; Gohda T; Suzuki Y; Yamagishi S; Tomino Y; Arai H
    Neurosci Lett; 2015 Apr; 593():51-5. PubMed ID: 25766756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease.
    Choei H; Sasaki N; Takeuchi M; Yoshida T; Ukai W; Yamagishi S; Kikuchi S; Saito T
    Acta Neuropathol; 2004 Sep; 108(3):189-93. PubMed ID: 15221334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycation of Ribonuclease A affects its enzymatic activity and DNA binding ability.
    Dinda AK; Tripathy DR; Dasgupta S
    Biochimie; 2015 Nov; 118():162-72. PubMed ID: 26365067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic β-cells.
    Hachiya H; Miura Y; Inoue K; Park KH; Takeuchi M; Kubota K
    J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):134-41. PubMed ID: 23798335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructose-human serum albumin interaction undergoes numerous biophysical and biochemical changes before forming AGEs and aggregates.
    Zaman A; Arif Z; Moinuddin ; Alam K
    Int J Biol Macromol; 2018 Apr; 109():896-906. PubMed ID: 29133088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients.
    Mao Z; Baker JR; Takeuchi M; Hyogo H; Tjønneland A; Eriksen AK; Severi G; Rothwell J; Laouali N; Katzke V; Kaaks R; Schulze MB; Palli D; Sieri S; de Magistris MS; Tumino R; Sacerdote C; Derksen JWG; Gram IT; Skeie G; Sandanger TM; Quirós JR; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Guevara M; Harlid S; Johansson I; Perez-Cornago A; Freisling H; Gunter M; Weiderpass E; Heath AK; Aglago E; Jenab M; Fedirko V
    Int J Cancer; 2023 Jun; 152(11):2257-2268. PubMed ID: 36715363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species.
    Niiya Y; Abumiya T; Shichinohe H; Kuroda S; Kikuchi S; Ieko M; Yamagishi S; Takeuchi M; Sato T; Iwasaki Y
    Brain Res; 2006 Sep; 1108(1):179-87. PubMed ID: 16872585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan.
    Takeuchi M; Takino J; Furuno S; Shirai H; Kawakami M; Muramatsu M; Kobayashi Y; Yamagishi S
    PLoS One; 2015; 10(3):e0118652. PubMed ID: 25730321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.
    Takeuchi M; Sakasai-Sakai A; Takata T; Ueda T; Takino J; Tsutsumi M; Hyogo H; Yamagishi S
    Med Hypotheses; 2015 May; 84(5):490-3. PubMed ID: 25697114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.
    Sotokawauchi A; Nakamura N; Matsui T; Higashimoto Y; Yamagishi SI
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review.
    Sakasai-Sakai A; Takata T; Takino JI; Takeuchi M
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
    Sakasai-Sakai A; Takata T; Takeuchi M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
    Dong Z; Iwata D; Kitaichi N; Takeuchi M; Sato M; Endo N; Iwabuchi K; Ando R; Fukuhara J; Kinoshita S; Lennikov A; Kitamura M; Mizuuchi K; Kanda A; Noda K; Namba K; Yamagishi S; Ohno S; Ishida S
    J Leukoc Biol; 2014 Dec; 96(6):1077-85. PubMed ID: 25201803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte or serum albumin protein carbonylation by oxidized fructose metabolites: Glyceraldehyde or glycolaldehyde as endogenous toxins?
    Dong Q; Yang K; Wong SM; O'Brien PJ
    Chem Biol Interact; 2010 Oct; 188(1):31-7. PubMed ID: 20561512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.